CRLCharles River LaboratoriesHealth Care
$180.71EarningsAug 5, 2026
1D—1W—1M—3M—1Y—
Market cap$8.8BCompany infoRevenue$4.0B52-wk range$146 – $231IndustryMedical - Diagnostics & ResearchWebsitecriver.comRelated
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +54.1% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S2.2×5864
2
7
P / FCF22.6×4139
13
52
EV / EBITDA14.6×4751
12
31
P / E (fwd)16.3×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin31.9%2820
32%
38%
Operating margin11.8%3839
3%
18%
Net margin-4.6%714
-5%
12%
ROE-5.8%917
-6%
18%
ROIC6.2%3437
2%
10%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity1.043222
0.6
1.2
Net debt / EBITDA3.6×2415
Current ratio1.365027
Interest coverage4.5×4136
Per shareTTM, with year-over-year change
Revenue / share$82.27▲ +0%
EPS (diluted)$-3.76▼ −478%
FCF / share$7.99▼ −31%
Est. EPS growth (fwd)+11%